Department of Pharmacological Modeling, M&S Decisions, Moscow, Russia.
Department of Pharmacological Modeling, M&S Decisions, Moscow, Russia.
Cell Mol Gastroenterol Hepatol. 2020;10(1):149-170. doi: 10.1016/j.jcmgh.2020.02.005. Epub 2020 Feb 26.
BACKGROUND & AIMS: Disturbances of the enterohepatic circulation of bile acids (BAs) are seen in a number of clinically important conditions, including metabolic disorders, hepatic impairment, diarrhea, and gallstone disease. To facilitate the exploration of underlying pathogenic mechanisms, we developed a mathematical model built on quantitative physiological observations across different organs.
The model consists of a set of kinetic equations describing the syntheses of cholic, chenodeoxycholic, and deoxycholic acids, as well as time-related changes of their respective free and conjugated forms in the systemic circulation, the hepatoportal region, and the gastrointestinal tract. The core structure of the model was adapted from previous modeling research and updated based on recent mechanistic insights, including farnesoid X receptor-mediated autoregulation of BA synthesis and selective transport mechanisms. The model was calibrated against existing data on BA distribution and feedback regulation.
According to model-based predictions, changes in intestinal motility, BA absorption, and biotransformation rates affected BA composition and distribution differently, as follows: (1) inhibition of transintestinal BA flux (eg, in patients with BA malabsorption) or acceleration of intestinal motility, followed by farnesoid X receptor down-regulation, was associated with colonic BA accumulation; (2) in contrast, modulation of the colonic absorption process was predicted to not affect the BA pool significantly; and (3) activation of ileal deconjugation (eg, in patents with small intestinal bacterial overgrowth) was associated with an increase in the BA pool, owing to higher ileal permeability of unconjugated BA species.
This model will be useful in further studying how BA enterohepatic circulation modulation may be exploited for therapeutic benefits.
胆汁酸(BAs)的肠肝循环紊乱可见于多种临床重要疾病,包括代谢紊乱、肝损伤、腹泻和胆石病。为了促进对潜在发病机制的探索,我们开发了一个基于不同器官定量生理观察的数学模型。
该模型由一组描述胆酸、鹅脱氧胆酸和脱氧胆酸合成的动力学方程组成,以及它们各自在体循环、肝门静脉区和胃肠道中的游离和结合形式的时间相关变化。该模型的核心结构是从以前的建模研究中改编而来,并根据最近的机制见解进行了更新,包括法尼醇 X 受体介导的 BA 合成的自动调节和选择性转运机制。该模型通过对现有的 BA 分布和反馈调节数据进行校准。
根据基于模型的预测,肠道蠕动、BA 吸收和生物转化率的变化对 BA 组成和分布的影响不同,具体如下:(1)抑制跨肠 BA 通量(例如,在 BA 吸收不良的患者中)或加速肠道蠕动,随后法尼醇 X 受体下调,与结肠 BA 积累有关;(2)相比之下,调节结肠吸收过程预计不会显著影响 BA 池;(3)回肠去结合的激活(例如,在小肠细菌过度生长的患者中)与 BA 池的增加有关,这是由于未结合的 BA 物种在回肠中的渗透性更高。
该模型将有助于进一步研究 BA 肠肝循环调节如何可能被用于治疗益处。